DK3594199T3 - Krystallinsk 2-flour-3-nitrotoluen og proces til forberedelse deraf - Google Patents
Krystallinsk 2-flour-3-nitrotoluen og proces til forberedelse deraf Download PDFInfo
- Publication number
- DK3594199T3 DK3594199T3 DK18182368.3T DK18182368T DK3594199T3 DK 3594199 T3 DK3594199 T3 DK 3594199T3 DK 18182368 T DK18182368 T DK 18182368T DK 3594199 T3 DK3594199 T3 DK 3594199T3
- Authority
- DK
- Denmark
- Prior art keywords
- crystallinic
- nitrotoluene
- flour
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/07—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms
- C07C205/11—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings
- C07C205/12—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by halogen atoms having nitro groups bound to carbon atoms of six-membered aromatic rings the six-membered aromatic ring or a condensed ring system containing that ring being substituted by halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
- C07C201/06—Preparation of nitro compounds
- C07C201/16—Separation; Purification; Stabilisation; Use of additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18182368.3A EP3594199B1 (en) | 2018-07-09 | 2018-07-09 | Crystalline 2-fluoro-3-nitrotoluene and process for the preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3594199T3 true DK3594199T3 (da) | 2020-09-14 |
Family
ID=62904314
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18182368.3T DK3594199T3 (da) | 2018-07-09 | 2018-07-09 | Krystallinsk 2-flour-3-nitrotoluen og proces til forberedelse deraf |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US12162815B2 (da) |
| EP (1) | EP3594199B1 (da) |
| JP (1) | JP7407166B2 (da) |
| CN (1) | CN112654602B (da) |
| AU (1) | AU2019303323B2 (da) |
| CA (1) | CA3105559A1 (da) |
| CY (1) | CY1123514T1 (da) |
| DK (1) | DK3594199T3 (da) |
| ES (1) | ES2815899T3 (da) |
| HR (1) | HRP20201198T1 (da) |
| HU (1) | HUE052049T2 (da) |
| LT (1) | LT3594199T (da) |
| MX (1) | MX2021000348A (da) |
| PL (1) | PL3594199T3 (da) |
| PT (1) | PT3594199T (da) |
| SI (1) | SI3594199T1 (da) |
| WO (1) | WO2020011626A1 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7507735B2 (en) | 2004-06-17 | 2009-03-24 | Cytokinetics, Inc. | Compounds, compositions and methods |
| EP3821882A1 (en) | 2013-03-14 | 2021-05-19 | Amgen Inc. | Heterocyclic compounds and their uses |
| MX2021009594A (es) | 2017-06-30 | 2022-10-24 | Amgen Inc | Sintesis de omecamtiv mecarbil. |
| JP2020526483A (ja) | 2017-06-30 | 2020-08-31 | アムジエン・インコーポレーテツド | 心筋節活性化剤で心不全を治療する方法 |
| BR112020004800A2 (pt) | 2017-09-13 | 2020-09-24 | Amgen Inc. | compostos de bisamida ativantes do sarcômero e seus usos |
| EP3837009A1 (en) | 2018-08-17 | 2021-06-23 | Amgen, Inc | Salts and crystal forms of omecamtiv mecarbil |
| US12442027B2 (en) | 2018-12-18 | 2025-10-14 | Amgen Inc. | Method of reducing aromatic nitro compounds |
| IL302850A (en) | 2020-11-12 | 2023-07-01 | Amgen Inc | Methods of treating heart failure by administering OMECAMTIV MECARBIL |
| AU2022232919A1 (en) | 2021-03-10 | 2023-10-19 | Amgen Inc. | Synthesis of omecamtiv mecarbil |
| WO2024081611A1 (en) | 2022-10-11 | 2024-04-18 | Cytokinetics, Incorporated | Methods for treating heart failure by administering cardiac sarcomere activators |
| US11986474B1 (en) | 2023-06-27 | 2024-05-21 | Cytokinetics, Incorporated | Methods for treating heart failure by administering cardiac sarcomere activators |
| WO2026050494A1 (en) | 2024-08-29 | 2026-03-05 | Cytokinetics, Incorporated | Omecamtiv mecarbil for use in treating heart failure by activating cardiac sarcomere |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7507735B2 (en) | 2004-06-17 | 2009-03-24 | Cytokinetics, Inc. | Compounds, compositions and methods |
| TW200808321A (en) | 2005-12-15 | 2008-02-16 | Cytokinetics Inc | Certain chemical entities, compositions and methods |
| AR059339A1 (es) * | 2006-02-09 | 2008-03-26 | Chugai Pharmaceutical Co Ltd | Derivados de la cumarina para trastornos proliferativos de celulas, composicion farmaceutica y agente terapeutico que los contiene |
| CN101177400A (zh) | 2006-11-06 | 2008-05-14 | 吕铁环 | 一种生产2-氟-3-硝基甲苯的方法 |
| US8569378B2 (en) | 2007-07-20 | 2013-10-29 | Toshiyuki Sakai | p27 protein inducer |
| TWI648274B (zh) * | 2013-02-15 | 2019-01-21 | 英商葛蘭素史克智慧財產發展有限公司 | 作為激酶抑制劑之雜環醯胺類 （二） |
| EP3821882A1 (en) | 2013-03-14 | 2021-05-19 | Amgen Inc. | Heterocyclic compounds and their uses |
| JP6634368B2 (ja) | 2013-03-14 | 2020-01-22 | アムジエン・インコーポレーテツド | 複素環式化合物及びそれらの使用 |
| EP3250557B1 (en) | 2015-01-29 | 2024-11-20 | Signal Pharmaceuticals, LLC | Isotopologues of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide |
| JP6858716B2 (ja) | 2015-06-26 | 2021-04-14 | アムジエン・インコーポレーテツド | 心筋ミオシン活性化剤と洞房結節Ｉｆ電流阻害剤の併用療法 |
| EP3266773B1 (en) * | 2016-07-04 | 2018-04-11 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Process for the preparation of lapatinib ditosylate monohydrate by means of an improved crystallization procedure |
| MX2021009594A (es) | 2017-06-30 | 2022-10-24 | Amgen Inc | Sintesis de omecamtiv mecarbil. |
| JP2020526483A (ja) | 2017-06-30 | 2020-08-31 | アムジエン・インコーポレーテツド | 心筋節活性化剤で心不全を治療する方法 |
| EP3837009A1 (en) | 2018-08-17 | 2021-06-23 | Amgen, Inc | Salts and crystal forms of omecamtiv mecarbil |
| US12442027B2 (en) | 2018-12-18 | 2025-10-14 | Amgen Inc. | Method of reducing aromatic nitro compounds |
| WO2021163172A1 (en) | 2020-02-10 | 2021-08-19 | Amgen Inc. | Omecamtiv mecarbil tablet |
| IL302850A (en) | 2020-11-12 | 2023-07-01 | Amgen Inc | Methods of treating heart failure by administering OMECAMTIV MECARBIL |
| AU2022232919A1 (en) | 2021-03-10 | 2023-10-19 | Amgen Inc. | Synthesis of omecamtiv mecarbil |
-
2018
- 2018-07-09 DK DK18182368.3T patent/DK3594199T3/da active
- 2018-07-09 PT PT181823683T patent/PT3594199T/pt unknown
- 2018-07-09 ES ES18182368T patent/ES2815899T3/es active Active
- 2018-07-09 PL PL18182368T patent/PL3594199T3/pl unknown
- 2018-07-09 HU HUE18182368A patent/HUE052049T2/hu unknown
- 2018-07-09 SI SI201830120T patent/SI3594199T1/sl unknown
- 2018-07-09 LT LTEP18182368.3T patent/LT3594199T/lt unknown
- 2018-07-09 EP EP18182368.3A patent/EP3594199B1/en active Active
-
2019
- 2019-07-03 WO PCT/EP2019/067894 patent/WO2020011626A1/en not_active Ceased
- 2019-07-03 US US17/258,385 patent/US12162815B2/en active Active
- 2019-07-03 AU AU2019303323A patent/AU2019303323B2/en active Active
- 2019-07-03 CA CA3105559A patent/CA3105559A1/en active Pending
- 2019-07-03 CN CN201980058205.6A patent/CN112654602B/zh active Active
- 2019-07-03 JP JP2021500471A patent/JP7407166B2/ja active Active
- 2019-07-03 MX MX2021000348A patent/MX2021000348A/es unknown
-
2020
- 2020-07-30 HR HRP20201198TT patent/HRP20201198T1/hr unknown
- 2020-09-15 CY CY20201100873T patent/CY1123514T1/el unknown
-
2024
- 2024-11-06 US US18/939,410 patent/US20250179005A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| PL3594199T3 (pl) | 2020-11-16 |
| CN112654602B (zh) | 2025-05-16 |
| MX2021000348A (es) | 2021-06-08 |
| US20210292271A1 (en) | 2021-09-23 |
| US12162815B2 (en) | 2024-12-10 |
| JP7407166B2 (ja) | 2023-12-28 |
| PT3594199T (pt) | 2020-09-04 |
| EP3594199B1 (en) | 2020-07-01 |
| LT3594199T (lt) | 2020-11-10 |
| AU2019303323A1 (en) | 2021-01-28 |
| US20250179005A1 (en) | 2025-06-05 |
| WO2020011626A1 (en) | 2020-01-16 |
| EP3594199A1 (en) | 2020-01-15 |
| CA3105559A1 (en) | 2020-01-16 |
| HUE052049T2 (hu) | 2021-04-28 |
| ES2815899T3 (es) | 2021-03-31 |
| AU2019303323B2 (en) | 2024-08-22 |
| SI3594199T1 (sl) | 2020-10-30 |
| CY1123514T1 (el) | 2022-03-24 |
| CN112654602A (zh) | 2021-04-13 |
| JP2021532076A (ja) | 2021-11-25 |
| HRP20201198T1 (hr) | 2020-11-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3784283T3 (da) | Cannabidiopræparater og anvendelser deraf | |
| DK3774789T3 (da) | BRM-målrettede forbindelser og tilhørende fremgangsmåder til anvendelse | |
| DK3796711T3 (da) | Fremgangsmåde og indretning til overdragelse | |
| DK3610005T3 (da) | Peptidligase og anvendelse deraf | |
| DK3788044T3 (da) | RIP1-hæmmende forbindelser og fremgangsmåder til fremstilling og anvendelse heraf | |
| DK3625263T3 (da) | Anti-galectin- 9-antistoffer og anvendelser deraf | |
| DK3601358T5 (da) | Anti-trem2-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3618863T3 (da) | Anti-tigit-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3383916T3 (da) | Anti-CD73-antistoffer og anvendelser deraf | |
| DK3689076T3 (da) | PDCP-UL-opdeling og forbehandling | |
| DK3788045T3 (da) | RIP1-hæmmende forbindelser og fremgangsmåder til fremstilling og anvendelse deraf | |
| DK3668512T3 (da) | Pyruvatkinasemodulatorer og anvendelse deraf | |
| IL268815A (en) | Compositions and methods for tumor transduction | |
| DK3529257T3 (da) | Oxysteroler og fremgangsmåder til anvendelse deraf | |
| DK3390444T3 (da) | Anti-tl1a-antigenbindende proteiner og anvendelser deraf | |
| DK3265947T3 (da) | Fremgangsmåde og system til kryptering | |
| DK4105223T3 (da) | Oxysteroler og fremgangsmåder til anvendelse deraf | |
| DK3828194T3 (da) | Oxysteroler og fremgangsmåder til anvendelse deraf | |
| DK3280441T3 (da) | Anti-sortilin-antistoffer og fremgangsmåder til anvendelse deraf | |
| DK3692009T3 (da) | Biocementationsfremgangsmåde og system | |
| DK3596125T3 (da) | Anti-PAR2-antistoffer og anvendelser deraf | |
| DK3704227T3 (da) | Sammensætning og fremgangsmåde | |
| DK3394065T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon og fremgangsmåder til anvendelse deraf | |
| DK3240895T3 (da) | Sammensætninger og fremgangsmåder til proteinglykosylering | |
| DK3812392T3 (da) | Oxysteroler og fremgangsmåder til anvendelse deraf |